LoginSignup
Tilray logo

Tilray

Stock
Stock
ISIN: US88688T1007
Ticker: TLRY
US88688T1007
TLRY

Price

Price

Frequently asked questions

What is Tilray's market capitalization?

The market capitalization of Tilray is $1.17B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Tilray?

Tilray's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.275. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Tilray's stock?

Currently, 14 analysts cover Tilray's stock, with a consensus target price of $2.345. Analyst ratings provide insights into the stock's expected performance.

What is Tilray's revenue over the trailing twelve months?

Over the trailing twelve months, Tilray reported a revenue of $812.04M.

What is the EBITDA for Tilray?

Tilray's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $25.78M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Tilray?

Tilray has a free cash flow of -$82.20M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Tilray's stock?

The 5-year beta for Tilray is 2.13. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Tilray have, and what sector and industry does it belong to?

Tilray employs approximately 2,650 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Tilray's shares?

The free float of Tilray is 897.22M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $1.17B

5Y beta

 2.13

EPS (TTM)

 -$0.275

Free Float

 897.22M

Revenue (TTM)

 $812.04M

EBITDA (TTM)

 $25.78M

Free Cashflow (TTM)

 -$82.20M

Pricing

1D span
$1.285$1.359
52W span
$1.28$2.97

Analyst Ratings

The price target is $2.345 and the stock is covered by 14 analysts.

Buy

3

Hold

11

Sell

0

Information

Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.

2,650

Biotechnology & Drugs

Health Care

Identifier

ISIN

US88688T1007

Primary Ticker

TLRY

Knockouts

Join the conversation
Sign upLogin